• Company
• 'Vyndamax' fails reimbursement listing once again
• by Eo, Yun-Ho Oct 27, 2021 05:49am

• Policy
• Development of generics for DPP4+SGLT2 has begun
• by Lee, Tak-Sun Oct 27, 2021 05:49am

• Company
• The supply of 8 GSK vaccines will be suspended until Feb
• by Oct 27, 2021 05:49am

• Policy
• Samsung Bio’s Moderna vaccine receives GMP certification
• by Lee, Tak-Sun Oct 27, 2021 05:49am

• Company
• Celltrion's self-test kit has been approved for EUA
• by Chon, Seung-Hyun Oct 27, 2021 05:49am

• Company
• Sales of choline alfoscerate rise despite controversy
• by Chon, Seung-Hyun Oct 26, 2021 05:53am

• Policy
• Dongkook started developing Dukarb's IMD
• by Lee, Tak-Sun Oct 26, 2021 05:53am

• Policy
• Up to 500 ppl will be allowed at events from next month
• by Kim, Jung-Ju Oct 26, 2021 05:53am

• Policy
• Hanmi Pharmaceutical's Esomezole Plus has been approved
• by Lee, Tak-Sun Oct 26, 2021 05:53am

• Company
• Merck will actively support Korea to become one of the top 5
• by Oct 26, 2021 05:53am